Research Library — Page 11 | Reta Compare
402 research articles. Page 11 of 17.
Articles
- Exploring Retatrutide: Insights from the LY3437943 Study in Type 2 Diabetes
- Exploring the Safety Profile of Retatrutide: Insights from Clinical Trial NCT03841630
- Advancements in Retatrutide Research: Surgical Threshold Crossed
- Retatrutide Achieves Significant Weight Loss Results in Recent Study
- Exploring Retatrutide: A Promising Weight Loss Agent Awaiting Approval
- Exploring Retatrutide: A Distinct Approach to Weight Loss Compared to Ozempic
- Evaluating the Safety Profile of Retatrutide in Comparison to Ozempic
- Exploring Side Effects of Retatrutide: Insights from Four Months of Use
- Comparing Retatrutide and Tirzepatide: Insights for Advanced Research
- Exploring Retatrutide: A New GLP-1 Injection for Metabolic Health
- Exploring Retatrutide: A New Era in GLP-1 Injection Therapy
- Understanding Retatrutide: Insights on Safety and Side Effects
- Exploring the Potential of Retatrutide for Weight Loss and Longevity
- Comparative Insights on Retatrutide for Weight Control Against Tirzepatide
- Understanding How to Access Retatrutide for Research and Clinical Use
- Exploring the Buzz Around Retatrutide: A New Weight-Loss Peptide
- Exploring the Early Results of Retatrutide for Weight Loss in 2026
- Exploring Retatrutide: Insights on Weight Loss and Its Comparison to Other Peptides
- Retatrutide Shows Promising Results in Phase 3 Trial for Type 2 Diabetes Management
- Retatrutide Demonstrates Significant Weight Loss and A1C Improvements in Phase 3 Trial
- Retatrutide Achieves Phase III Metabolic Targets in Recent Clinical Trials
- Exploring the Weight-Centric Focus of Retatrutide in Clinical Perspectives
- Exploring the Impact of Retatrutide on Weight Loss and Metabolic Health
- Exploring the Role of Retatrutide in Next Generation GLP-1 Therapies
- Retatrutide Demonstrates 24% Weight Loss in TRIUMPH Program Findings